Cathie Wood's ARK Invest Buys Over 850,000 Shares of UiPath

Investing

Published: June 30, 2021 9:15 am

A couple of the ARK Invest exchange-traded funds run by ETF star Cathie Wood made huge purchases on Tuesday. Altogether, these funds bought over 850,000 shares of UiPath Inc. (NYSE: PATH) on Tuesday, as the price of these ETFs gained less than 1% on Tuesday. Note that these funds are still up handily in the last year.

ARK Genomic Revolution ETF (NYSEARCA: ARKG) bought 291,229 shares of UiPath, and ARK Innovation ETF (NYSEARCA: ARKK) bought 566,900 shares. At Tuesday’s closing price, this would have valued these purchases at roughly $59.1 million. Even though this is a small fraction of the total holdings, every little bit counts. ARKG is up 84% in the past year and ARKK is up 92%.

Check out all of ARK Invest’s buys for Tuesday:

Fund	Ticker	Company	Shares
ARKG	IONS	Ionis Pharmaceuticals	268,748
ARKG	PATH	UIPath	291,229
ARKK	PATH	UIPath	566,900
ARKQ	KTOS	Kratos Defense & Security Solutions	50,625
ARKQ	BZ	Kanzhun	109,718
ARKW	BZ	Kanzhun	101,005
ARKW	VUZI	Vuzix	232,063

Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St.

24/7 Wall St.
Top Market Strategist Says a Vicious 10% Correction Very Possible by November

Travel Cards Are Getting Too Good To Ignore (sponsored)

Credit card companies are pulling out all the stops, with the issuers are offering insane travel rewards and perks.

We’re talking huge sign-up bonuses, points on every purchase, and benefits like lounge access, travel credits, and free hotel nights. For travelers, these rewards can add up to thousands of dollars in flights, upgrades, and luxury experiences every year.

It’s like getting paid to travel — and it’s available to qualified borrowers who know where to look.

We’ve rounded up some of the best travel credit cards on the market. Click here to see the list. Don’t miss these offers — they won’t be this good forever.